<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Research in Dental and Maxillofacial Sciences</title>
<title_fa></title_fa>
<short_title>J Res Dent Maxillofac Sci</short_title>
<subject>Medical Sciences</subject>
<web_url>http://jrdms.dentaliau.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2588-4166</journal_id_issn>
<journal_id_issn_online>2383-2754</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/jrdms</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1398</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2019</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<volume>4</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Use of Topical 5-Fluorouracil for Keratocystic Odontogenic Tumors of Gorlin-Goltz Syndrome as a New Targeted Therapy: A Case Report and Review of Literature</title>
	<subject_fa>Oral &amp; maxillofacial surgery</subject_fa>
	<subject>Oral &amp; maxillofacial surgery</subject>
	<content_type_fa></content_type_fa>
	<content_type>Case report</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Keratocystic odontogenic tumors (KOT) have a high rate of recurrence, which is higher in patients diagnosed with Gorlin-Goltz syndrome (GGS). Adjunctive therapies, such as fixative chemical solutions, decrease the rate of recurrence after enucleation and peripheral ostectomy but have high morbidity rates. Topical 5-Fluorouracil (5-FU) has been suggested as a new therapy that provides a directed molecular approach to treatment. &lt;span dir=&quot;RTL&quot;&gt;&lt;/span&gt;&lt;br&gt;
&lt;strong&gt;Case Presentation:&lt;/strong&gt; This is a case report of GGS treated using topical 5-FU as an adjunctive material after enucleation and peripheral ostectomy. New bone formation sites were identified in the radiographic follow-up. The patient was followed up for 10 months regularly without any evidence of recurrence.&lt;br&gt;
&lt;strong&gt;Conclusion: &lt;/strong&gt;5-FlU is an effective and novel targeted treatment for KOTs. Topical application of 5-FU, following&lt;br&gt;
enucleation and peripheral ostectomy, effectively treats syndromic KOTs, resulting in normal bony healing with no adverse local or systemic effects.&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Odontogenic Tumors, Basal Cell Nevus Syndrome, Recurrence, 5-fluorouracil, salicylic acid drug combination [Supplementary Concept]</keyword>
	<start_page>43</start_page>
	<end_page>48</end_page>
	<web_url>http://jrdms.dentaliau.ac.ir/browse.php?a_code=A-10-694-2&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>hossein</first_name>
	<middle_name></middle_name>
	<last_name>shiran</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hossein.shiran@gmail.com</email>
	<code>10031947532846009775</code>
	<orcid>10031947532846009775</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Postgraduate Student, Oral and Maxillofacial Surgery Dept, Faculty of Dentistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>SH</first_name>
	<middle_name></middle_name>
	<last_name>Shafaei Fard</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846009776</code>
	<orcid>10031947532846009776</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Associated Professor,  Oral and Maxillofacial Surgery Dept , Faculty of Dentistry, Tehran Medical Sciences, </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>S</first_name>
	<middle_name></middle_name>
	<last_name>Hakimi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846009777</code>
	<orcid>10031947532846009777</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Associated Professor , Oral and Maxillofacial Surgery Dept, Faculty of Dentistry,Medical Sciences University of Zahedan,Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>A</first_name>
	<middle_name></middle_name>
	<last_name>Azari Pour Esfahani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846009778</code>
	<orcid>10031947532846009778</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Postgraduate Student, Oral and Maxillofacial Surgery Dept,Faculty of Dentistry, Tehran Medical Sciences, </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
